https://www.selleckchem.com/pr....oducts/Ubenimex(Best
of freedom of pain at 2h and sustained pain relief at 2-24h compared with the 100-mg dose (freedom of pain at 2h lasmiditan, 34.53%; placebo, 28.67%; RR 1.2 [95% CI 1.04-1.38]; lasmiditan, 20.62%; placebo, 16.33%; RR 1.26 [95% CI 1.19-1.34]), with low heterogeneity for both outcomes (I = 0%). In this meta-analysis, the use of lasmiditan as an acute treatment for episodic migraine in adults led to a greater percentage of freedom of pain and the absence of the most bothersome symptoms at 2h post-dose. Lasmiditan 200mg had supe
Like
Comment
Share
